替罗非班联合急诊冠脉介入治疗急性心肌梗死临床分析(1)
[摘要] 目的 观察并分析替罗非班联合急诊冠脉介入治疗急性心肌梗死临床疗效。方法 方便选取180例2015年8月—2017年8月在该院治疗的急性心肌梗死患者。将其分为对照组和观察组，各90例，对照组给予单纯的急诊冠脉介入治疗，观察组患者给予替罗非班联合急诊冠脉介入治疗。观察并比较两组患者在治疗前后TIMI血流分级情况以及患者时候30 d主要心血管时间的发生率。 结果 观察组患者治疗后的TIMI血流分级情况以及心血管事件的发生率(5.56%)均优于对照组，差异有统计学意义(χ2=6.951，P<0.05)。 结论 在治疗急性心肌梗死患者时，给患者给予替罗非班联合急诊冠脉介入治疗，能够有效的提高患者的生存率，此种治疗方法安全可靠，在临床上具有较高的推广价值。
[關键词] 替罗非班；急诊冠脉介入治疗；急性心肌梗死；临床；观察
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2018)03(b)-0132-03
Clinical Analysis of Tirofiban Combined with Emergency Coronary Interventional Treatment of Acute Myocardial Infarction
YU Hai
Department of Cardiology， Yuxi People’s Hospital， Yuxi， Yunnan Province， 653100 China
[Abstract] Objective To observe and analyze the clinical curative effect of tirofiban combined with emergency coronary interventional treatment of acute myocardial infarction. Methods 180 cases of patients with acute myocardial infarction admitted and treated in our hospital from August 2015 to August 2017 were convenient selected and divided into two groups with 90 cases in each， the control group used the simple emergency coronary interventional therapy， while the observation group used the tirofiban combined with emergency coronary interventional treatment， and the TIMI blood flow classification and incidence rate of 30d major cardiovascular time before and after treatment were compared and observed. Results After treatment， the TIMI blood flow classification and incidence rate of cardiovascular events in the observation group was 5.56%， which were better than those in the control group， and the difference was obvious， with statistical significance(χ2=6.951，P<0.05). Conclusion The tirofiban combined with emergency coronary interventional treatment of acute myocardial infarction can effectively improve the survival rate of patients， and it is safe and reliable， which is of higher promotion and application value.
[Key words] Tirofiban； Emergency coronary interventional treatment； Acute myocardial infarction； Clinic； Observation
急性心肌梗死主要是由于患者的动脉粥样硬化斑块破裂，使其形成了血栓。从而导致患者的冠状动脉发生堵塞而造成的。目前，临床上治疗急性心肌梗死疾病的有效治疗方法就是急诊冠脉介入治疗，但是在用此种方法进行治疗时，当患者的动脉粥样硬化斑块形成血栓或者破裂脱落之后，会造成患者的远端血管发生堵塞，这也就在很大程度上影响了急诊冠脉介入治疗的效果[1]。该文方便选取了180例2015年8月—2017年8月在该院治疗的急性心肌梗死患者。对其中的90例给予替罗非班联合急诊冠脉介入治疗。取得了显著的治疗效果，现报道如下。
1 资料与方法
1.1 一般资料
方便选取180例在该院治疗的急性心肌梗死患者。将其分为对照组和观察组，各90例。所有患者经过检查均被确诊为急性心肌梗死患者。该次研究的项目通过了医院伦理委员会的批准，患者以及患者家属均签署了知情同意书。该组患者均对照组中男52例，女38例，年龄37～78岁，平均年龄(58.2±9.6)岁；观察组中男50例，女40例，年龄38～76岁，平均年龄(57.9±9.4)岁；两组患者的一般资料差异无统计学意义(P>0.05)。, 百拇医药(余海)
[關键词] 替罗非班；急诊冠脉介入治疗；急性心肌梗死；临床；观察
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2018)03(b)-0132-03
Clinical Analysis of Tirofiban Combined with Emergency Coronary Interventional Treatment of Acute Myocardial Infarction
YU Hai
Department of Cardiology， Yuxi People’s Hospital， Yuxi， Yunnan Province， 653100 China
[Abstract] Objective To observe and analyze the clinical curative effect of tirofiban combined with emergency coronary interventional treatment of acute myocardial infarction. Methods 180 cases of patients with acute myocardial infarction admitted and treated in our hospital from August 2015 to August 2017 were convenient selected and divided into two groups with 90 cases in each， the control group used the simple emergency coronary interventional therapy， while the observation group used the tirofiban combined with emergency coronary interventional treatment， and the TIMI blood flow classification and incidence rate of 30d major cardiovascular time before and after treatment were compared and observed. Results After treatment， the TIMI blood flow classification and incidence rate of cardiovascular events in the observation group was 5.56%， which were better than those in the control group， and the difference was obvious， with statistical significance(χ2=6.951，P<0.05). Conclusion The tirofiban combined with emergency coronary interventional treatment of acute myocardial infarction can effectively improve the survival rate of patients， and it is safe and reliable， which is of higher promotion and application value.
[Key words] Tirofiban； Emergency coronary interventional treatment； Acute myocardial infarction； Clinic； Observation
急性心肌梗死主要是由于患者的动脉粥样硬化斑块破裂，使其形成了血栓。从而导致患者的冠状动脉发生堵塞而造成的。目前，临床上治疗急性心肌梗死疾病的有效治疗方法就是急诊冠脉介入治疗，但是在用此种方法进行治疗时，当患者的动脉粥样硬化斑块形成血栓或者破裂脱落之后，会造成患者的远端血管发生堵塞，这也就在很大程度上影响了急诊冠脉介入治疗的效果[1]。该文方便选取了180例2015年8月—2017年8月在该院治疗的急性心肌梗死患者。对其中的90例给予替罗非班联合急诊冠脉介入治疗。取得了显著的治疗效果，现报道如下。
1 资料与方法
1.1 一般资料
方便选取180例在该院治疗的急性心肌梗死患者。将其分为对照组和观察组，各90例。所有患者经过检查均被确诊为急性心肌梗死患者。该次研究的项目通过了医院伦理委员会的批准，患者以及患者家属均签署了知情同意书。该组患者均对照组中男52例，女38例，年龄37～78岁，平均年龄(58.2±9.6)岁；观察组中男50例，女40例，年龄38～76岁，平均年龄(57.9±9.4)岁；两组患者的一般资料差异无统计学意义(P>0.05)。, 百拇医药(余海)